➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
Dow
Express Scripts
Johnson and Johnson
Merck

Last Updated: June 22, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Givinostat


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Givinostat?

Givinostat is an investigational drug.

There have been 9 clinical trials for Givinostat. The most recent clinical trial was a Phase 2 trial, which was initiated on October 1st 2016.

The most common disease conditions in clinical trials are Muscular Dystrophy, Duchenne, Muscular Dystrophies, and Polycythemia. The leading clinical trial sponsors are Italfarmaco, inVentiv Health Clinical, and Parexel.

There are three hundred and seventeen US patents protecting this investigational drug and two international patents.

Recent Clinical Trials for Givinostat
TitleSponsorPhase
Placebo-Corrected Effects of Therapeutic Dose (100 mg) and Supratherapeutic Dose (300 mg) of ITF2357 (Givinostat) and Moxifloxacin on QT/QTC IntervalItalfarmacoPhase 1
Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Becker Muscular DystrophyItalfarmacoPhase 2
Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular DystrophyinVentiv Health ClinicalPhase 3

See all Givinostat clinical trials

Clinical Trial Summary for Givinostat

Top disease conditions for Givinostat
Top clinical trial sponsors for Givinostat

See all Givinostat clinical trials

US Patents for Givinostat

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Givinostat   Try Before You Buy Histone deacetylase inhibitors and methods for use thereof REACTION BIOLOGY CORP. (Malvern, PA)   Try Before You Buy
Givinostat   Try Before You Buy Anti-CS1 antibodies and antibody drug conjugates AbbVie Biotherapeutics Inc. (Redwood City, CA)   Try Before You Buy
Givinostat   Try Before You Buy Histone deacetylase 6 inhibition for enhancing T-cell function during anti-tumor response and tumor-peptide vaccination H. Lee Moffitt Cancer Center and Research Institute, Inc. (Tampa, FL)   Try Before You Buy
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Givinostat

Drugname Country Document Number Estimated Expiration Related US Patent
Givinostat World Intellectual Property Organization (WIPO) WO2017030892 2035-08-14   Try Before You Buy
Givinostat Australia AU2015339012 2034-10-31   Try Before You Buy
Givinostat Brazil BR112017008945 2034-10-31   Try Before You Buy
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Express Scripts
Medtronic
Harvard Business School
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.